Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Awards
2021
Zhaoke Ophthalmology Limited Successfully listed on Main Board of the StockExchange of hong kong Limited (Stock code:6622) on 29 Apeil 2021
2020
Successfully raised approximately US$145 million through the private placement of series B preferred shares fo Zhaoke Ophthalmology Limited in October 2020
2019
Successfully raised approximately US$50 million through the private placement of series A preferred shares of China Ophthalmology Focus Limited in May 2019
Formation of Lee’s Pharmaceutical Taiwan Limited, registered and operated in Taiwan on 9 April 2019
2018
Completed the merger of CVie Therapeutics Limited with Windtree Therapeutics, Inc. in December 2018
2017
Completed the acquisition of majority of shares in Windtree Therapeutics, Inc. at a consideration of US$10 million in November 2017
Establishment of China Ophthalmology Focus Limited
Successfully carried out the reorganization of CVie Therapeutics Company Limited into two companies: CVie Therapeutics Limited for Taiwan business and CVie Therapeutics Company Limited for China business
Completed the acquisition of majority of shares in Windtree Therapeutics, Inc. at a consideration of US$10 million in November 2017
2016
Nansha Facility obtained Manufacturing License for tablet and Capsule on 30 June 2016
